Biotech · Private company · San Francisco, CA, US
Apogee Therapeutics, Inc.
SEC CIK 0001974640
Track this companyFree. Adds Apogee Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- APG777Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- APG777Phase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisPHASE2 · RECRUITING · started May 14, 2025ClinicalTrials.gov NCT07003425 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With AsthmaPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 27, 2025ClinicalTrials.gov NCT06920901 · fetched Nov 12, 2026
- A Study Evaluating APG777 in Atopic DermatitisPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 29, 2024ClinicalTrials.gov NCT06395948 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 11, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 24, 2026 · fetched Nov 12, 2026